Max A. Milbury's most recent trade in ProMIS Neurosciences Inc. was a trade of 70,000 Option (right to buy) done . Disclosure was reported to the exchange on Nov. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc. | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2024 | 70,000 | 70,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc. | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 13,297 | 14,997 | - | - | Common Shares | |
| ProMIS Neurosciences Inc. | Max A. Milbury | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 13,297 | 13,297 | - | - | Warrants to purchase Common Shares |